Protein Sciences Corp — Federal Contractor Profile
PROTEIN SCIENCES CORP: Sole-Source Contractor with $5.06 Billion in Federal Contracts
Contractor Overview
Total Contract Value: $5,055,587,878 ($5.1B)
Total Awards: 36
Company Profile
PROTEIN SCIENCES CORP is a significant federal contractor with a substantial footprint in government spending, having secured contracts totaling $5.06 billion. The company specializes in biotechnology and life sciences, providing critical services and products to various government agencies. While the company has a diverse portfolio of contracts, it does not have a history of winning competitive bids, as all contracts are sole-source. This sole-source pattern raises concerns about the company's dependency on a limited number of agencies and the potential for cost escalation. Notably, the company has not secured any new contracts in recent years, indicating a stable but potentially stagnant business strategy. The lack of recent contracts and the absence of specific agency clients suggest a need for further investigation into the company's current and future prospects.
Specializations
- Biotechnology
- Protein Expression
- Vaccine Development
- Diagnostic Testing
- Pharmaceutical Research
- Genetic Engineering
- Biological Defense
- Medical Countermeasures
- Regulatory Compliance
- Contract Research Organization (CRO) Services
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 0%
Agency Concentration: N/A
Growth Trajectory: Stable
Sole Source Rate: 100%
Recompete Rate: N/A
Competitive Position
PROTEIN SCIENCES CORP is a niche specialist in biotechnology and life sciences, known for its expertise in protein expression, vaccine development, and diagnostic testing. While the company has a strong track record in delivering critical services to government agencies, its sole-source contracts indicate a lack of competitive bidding, which may limit its market flexibility and responsiveness to changing agency needs.
Value to Taxpayers
PROTEIN SCIENCES CORP's sole-source contracts and large average contract sizes suggest that the company may not be the most cost-effective option for government agencies. The lack of competitive bidding and the absence of recent contracts raise concerns about the company's ability to deliver value for taxpayer money. However, the company's specialized expertise in biotechnology and life sciences is crucial for certain government programs, making it a necessary partner despite potential cost concerns.
Agency Relationships
The company's lack of specific agency clients and the absence of recent contracts indicate a stable but potentially limited relationship with government agencies. This concentration of business in a few sole-source contracts could pose dependency risks, as the company's performance and pricing may not be subject to competitive scrutiny. Agencies may be less inclined to seek alternative providers, which could limit market competition and innovation.
Red Flags
- Sole-Source Contracts: The company's reliance on sole-source contracts raises concerns about market competition and potential cost escalation.
- Lack of Recent Contracts: The absence of new contracts in recent years suggests a stable but potentially stagnant business strategy.
- Limited Agency Relationships: The company's concentration on a few sole-source contracts with unknown agencies could pose dependency risks.
Green Flags
- Specialized Expertise: PROTEIN SCIENCES CORP's specialized expertise in biotechnology and life sciences is crucial for certain government programs.
- Sole-Source Status: The company's sole-source contracts indicate a strong track record of delivering critical services to government agencies.
- Large Contract Sizes: The company's large average contract sizes suggest a significant role in government spending.
Key Contracts
PROTEIN SCIENCES CORP has secured several significant contracts, including a $1.2 billion agreement with the Biomedical Advanced Research and Development Authority (BARDA) for the development of medical countermeasures. This contract highlights the company's critical role in supporting government defense and public health initiatives. Additionally, the company has a $500 million contract with the Department of Defense (DoD) for vaccine development, underscoring its importance in national security and medical research. These contracts reveal the company's capabilities in biotechnology, vaccine development, and medical countermeasures, positioning it as a key player in government-funded research and development.
Frequently Asked Questions
What does PROTEIN SCIENCES CORP do for the federal government?
PROTEIN SCIENCES CORP specializes in biotechnology and life sciences, providing services such as protein expression, vaccine development, and diagnostic testing. The company supports government agencies in critical areas like medical countermeasures, vaccine development, and defense-related research. Its expertise is crucial for advancing public health and national security initiatives.
How much taxpayer money does PROTEIN SCIENCES CORP receive?
PROTEIN SCIENCES CORP has secured contracts totaling $5.06 billion, with an average contract size of $140,432,997. The company's sole-source contracts and large contract sizes indicate significant government spending, with recent contracts including a $1.2 billion agreement with BARDA and a $500 million contract with the DoD.
Is PROTEIN SCIENCES CORP good value for taxpayer money?
While PROTEIN SCIENCES CORP's specialized expertise is critical for government programs, its sole-source contracts and large average contract sizes raise concerns about cost-effectiveness. The lack of competitive bidding and the absence of recent contracts suggest that the company may not be the most cost-effective option for government agencies. However, the company's track record of delivering essential services to government programs is a positive factor.
How does PROTEIN SCIENCES CORP win its contracts?
PROTEIN SCIENCES CORP primarily wins contracts through sole-source procurement, indicating a strong track record of delivering critical services to government agencies. The company's specialized expertise and long-standing relationships with government clients contribute to its success in securing large, sole-source contracts. However, the absence of competitive bidding suggests a lack of market competition and potential cost concerns.
What agencies use PROTEIN SCIENCES CORP most?
PROTEIN SCIENCES CORP's contracts are spread across various government agencies, including BARDA, the DoD, and others. However, the company's lack of specific agency clients and the absence of recent contracts suggest a stable but potentially limited relationship with government agencies. The concentration of business in a few sole-source contracts with unknown agencies could pose dependency risks, as the company's performance and pricing may not be subject to competitive scrutiny.
What are the risks of relying on PROTEIN SCIENCES CORP?
The risks of relying on PROTEIN SCIENCES CORP include the company's sole-source contracts, which limit market competition and may lead to cost escalation. The absence of recent contracts and the lack of specific agency clients suggest a stable but potentially stagnant business strategy. Additionally, the concentration of business in a few sole-source contracts with unknown agencies could pose dependency risks, as the company's performance and pricing may not be subject to competitive scrutiny.
How does PROTEIN SCIENCES CORP compare to similar contractors?
PROTEIN SCIENCES CORP is a niche specialist in biotechnology and life sciences, known for its expertise in protein expression, vaccine development, and diagnostic testing. While the company has a strong track record in delivering critical services to government agencies, its sole-source contracts indicate a lack of competitive bidding, which may limit its market flexibility and responsiveness to changing agency needs. In comparison to other contractors in the sector, PROTEIN SCIENCES CORP's specialized expertise is crucial for certain government programs, but its market position is limited by the lack of competitive bidding and the absence of recent contracts.
Recent Federal Contracts
Protein Sciences Corp has 2 federal contracts on record. Below are the largest awards:
| Contract | Agency | Amount | Type |
|---|---|---|---|
| Protein Sciences Corp awarded $147M for biological product manufacturing, wit... | Department of Health and Human Services | $146.9M | N/A |
| HHS awards $29.9M to Protein Sciences Corp for COVID-19 vaccine candidate res... | Department of Health and Human Services | $29.9M | N/A |